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Objective: To compare the acupuncture plus oral administration of Chinese herbal decoction with simple 
oral administration of Chinese herbal decoction in the treatment of vascular headache. Methods: Sixty two 
patients were randomly divided into a treatment group (32 cases) and a control group (30 cases). 
Acupuncture at Baihui (GV 20), Fengchi (GB 20), Shuaigu (GB 8), Xingjian (LR 2), Neiguan (PC 6), 
Sanyinjiao (SP 6) and Ashi points combined with oral administration of Chinese herbal decoction, was 
applied in the treatment group, and simple oral administration of Chinese herbal decoction was applied in the 
control group. Results: The total therapeutic effect in the treatment group was better than that in the control 
group (P<0.05). After treatment, the frequency, and duration of the attacks were reduced and shortened, and 
headache greatly alleviated in both groups (P<0.01). The alleviation in the treatment group was more obvious 
than that in the control group (P<0.05). Conclusion: Acupuncture combined with oral administration of 
Chinese herbal decoction provided remarkable therapeutic effects in treating vascular headache. 
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Vascular headache is a common and frequently 
encountered disease characterized by repeated attacks 
of migraine mainly with severe symptoms but not 
many positive body signs. It pertains to the category 
of head-wind and brain-wind. Epidemiological 
investigation has shown that its incidence is 
985.2/100000, with an annual incidence rate of 
79.7/100000. It is more common in women than in 
men in a ratio of  to 1, and a peak onset period 
occurs between 25 to 29 years of age.1 By means of 
acupuncture combined with oral administration of 
Chinese herbal decoction, the authors treated 32 
cases of vascular headache and compared its effect 
with that in 30 cases treated by simple oral 
administration of Chinese herbal decoction. It is 
reported as follows.   
CLINICAL MATERIALS 
General Data 
By using a random digits table, 62 patients from the 
Clinic of Guoyitang Hospital of TCM, Beijing 
University of Traditional Chinese Medicine were 
divided into a treatment group (32 cases) and a 
control group (30 cases). Of the 32 cases in the 
treatment group, 12 cases were male and 20 cases 
female, ranging from 16 to 57 years with 26±11.5 on 
average in age and 3 months to 11 years in course of 
disease. According to headache attack severity and 
frequency, 4 severe, 17 moderate and 11 mild cases 
were included in this group. 2 Of the 30 cases in the 
control group, 8 cases were male and 22 cases female, 
ranging from 15 to 59 years with 28±12.4 on average
in age and 5 months to 13 years in course of disease. 
According to headache attack severity and frequency, 
3 severe, 14 moderate and 13 mild cases were 
included in this group. There were no significant 
differences in gender and severity, compared by 
using Ȥ2 test (P>0.05), and in age and course of 
disease, compared by using t-test, indicating 
comparability between the two groups.  
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Criteria for Diagnosis 
According to the Criteria for Diagnosis, Cure and 
Improvement of Clinical Diseases,3 vascular 
headache is manifested by head swelling pain, 
throbbing pain and stabbing pain, which are mostly 
induced by exertion, emotional factors or menstrual
onset. Frequently, there are such auras before the 
attack as amaurosis, flash of either light or dark spots, 
or appearance of vertigo. It hangs on for a long time 
or subsides but recurs, and comes on with dryness 
and bitterness in the mouth, and pale complexion, 
vexation-restlessness, nausea and vomiting in some 
patients. The examination reveals dark red or purplish 
tongue with thin yellow or yellow and greasy tongue 
coating and string-taut pulse. According to syndrome 
differentiation and based on guiding principles for 
clinical study on headache set in Guiding Principles 
for Clinical Study of New Chinese Medicines, this 
disease belongs to liver yang hyperactivity 
complicated with obstruction of collaterals by blood 
stasis.4  
Criteria for Case Inclusion and Exclusion 
The following cases were included: 1) the cases in 
accordance with the diagnostic criteria mentioned 
above; 2) those without abnormal findings in the 
nervous system shown by physical and image 
examinations; 3) those within the age of 15–60; 4) 
those signed the informed consent. 
The following cases were excluded: 1) the cases of 
headache induced by epilepsy, brain trauma, 
cerebrovascular accident, intracranial infection, 
intracranial spaceoccupying lesion and cephalic and 
facial neuralgia; 2) those induced by ophthalmic or 
systemic diseases. 
METHODS 
For the Treatment Group 
Acupuncture combined with oral administration of 
Chinese herbal decoction was applied in this group. 
Filiform needles were used for acupuncture at Baihui 
(GV 20), Fengchi (GB 20), Shuaigu (GB 8), Xingjian 
(LR 2), Neiguan (PC 6), Sanyinjiao (SP 6) and Ashi 
points. Taichong (LR 3) and Hegu (LI 4) were added 
to the cases with liver yang hyperactivity, and Xuehai 
(SP 10) was added to the cases with obstruction of 
collaterals by blood stasis. After routine sterilization, 
filiform needles made of stainless steel with 0.35 mm 
in diameter and 40 mm in length were inserted into 
the points to the depth achieving needling sensation, 
and then an even reinforcing and reducing maneuver 
was applied by lifting, thrusting and rotating, and the 
needles remained for 20 minutes, during which the 
needles were manipulated twice. The treatment was 
given once every other day. Chinese herbal decoction 
consisted of Tian Ma (໽咏 Rhizoma Gastrodiae) 
15g, Chuan Xiong (Ꮁ㡢 Rhizoma Chuanxiong) 12g, 
Dan Shen (Ѝখ Radix Salviae Miltiorrhizae) 12g, 
Chi Shao (䌸㡡 Radix Paeoniae Rubra) 15g, Bai 
Shao (ⱑ㡡 Radix Paeoniae Alba) 15g, Dang Gui 
(ᔧᔦ Radix Angelicae Sinensis) 12g, Fang Feng (䰆
亢 Radix Saposhnikoviae) 12g, Ju Hua (㦞㢅 Flos 
Chrysanthemi) 12g, Huang Qin ( 咘 㡽  Radix 
Scutellariae) 12g, Mai Dong ( 呺 ހ  Radix 
Ophiopogonis) 12g, Bai Zhi (ⱑ㢋 Radix Angelicae 
Dahuricae) 3g, Xi Xin (㒚䕯 Herba Asari) 3g, Man 
Jing Zi (㫧㤚ᄤ Fructus Viticis) 6g, and Gan Cao 
(⫬㤝 Radix Glycyrrhizae) 6g. For the cases with 
liver yang hyperactivity, Dai Zhe Shi (ҷ䍁⷇ Ochra 
Haematitum) 12g and Gou Teng (䩽㮸  Ramulus 
Uncariae cum Uncis) 10g were added, and for those 
with obstruction of collaterals by blood stasis, Tao 
Ren (ḗҕ Semen Persicae) 9g , and Shui Zhi (∈㳁
Leech) 3g were added. The drugs above-mentioned 
were decocted in water, and the decoction was taken 
at one dose per day in 2 equally divided doses taken 
respectively in the morning and evening.  
For the Control Group 
In this group, simple Chinese herbal decoction with 
the same components, dosage and modification as 
those mentioned in the treatment group was given. 
The patients in both groups were treated for 14 
successive days (a therapeutic course), and then the 
therapeutic effects were evaluated. 
Indices for Observation 
Grade of severity: According to Bussone’s method,5 
no pain was estimated as grade 0, mild pain as grade 
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I, moderate pain as grade II, severe pain as grade III, 
and extremely severe pain as grade IV. 
Frequency of attacks: Based on the number of 
attacking in each month, 1–2 attacks were evaluated 
as 1 score, 3–4 attacks as 2 scores, 5–6 attacks as 3 
scores, 7–8 attacks as 4 scores, and 9 and even more 
attacks as 5 scores. 
Number of days with attacks: According to number 
of days with attacks in each month, 1–2 days were 
evaluated as 1 score, 3–5 days as 2 scores, 6–8 days 
as 3 scores, 9–11 days as 4 scores, and 12–14 days as 
5 scores. 
Duration of attacks: For the cases with headache 
attack lasting for 30 minutes–12 hours were 
evaluated as 1 score, for 13 hours–1 day as 2 scores, 
2–3 days as 3 scores, 4–5 days as 4 scores, and 6–7
days as 5 scores. 
Scoring of headache intensity: By using Visual 
Analog Score (VAS), a ruler of 10 cm in length, in 
which one end represents no pain and the other one 
represents extremely severe pain, was used to let the 
patients point out the intensity of subjective feeling 
of pain. The length (L) between 0 to the point was 
scored as follows: the case with L 2 cm was 
evaluated as 1 score, that with 4 cm L >2 cm as 2 
scores, that with 6 cm L >4 cm as 3 scores, that with 
8 cm L >6 cm as 4 scores, that with L >8 cm as 5 
scores.  
Clinical general data: Headache attack time, 
frequency, severity, duration and cause, as well as 
corresponding body signs, tongue and pulse 
conditions, and body temperature were taken as 
clinical data for observation.  
Statistical Analysis 
All the data were shown by mean ± standard 
deviation (SD), and statistical analysis was made by 
using SAS6.12 software. Comparison of total 
effective rate was made by using CMH Ȥ2 test, and 
inter-group comparison of measurement data among 
groups made by t-test, and interior-group comparison 
by paired t-test.  
RESULTS 
Criteria for Therapeutic Effects 
Treatment effects were estimated based on the 
guiding principles for clinical study on headache set 
in Guiding Principles for Clinical Study of New 
Chinese Medicines.4 Disappearance of headache and 
the accompanied symptoms was taken as clinically 
cured; reduction of pain severity by 2 grades with 
alleviation of accompanied symptoms, or lessening of 
attacks or duration shortened by over two thirds was 
taken as relieved; reduction of pain severity by 1 
grade, or shortening of interval of two consecutive
attacks or duration reduced by less than two thirds 
was taken as improved; reduction of pain severity by 
less than 1 grade, or shortening of duration by less 
than one third, or even with aggravated and 
prolonged duration of pain was taken as failed. 
Comparison of Total Therapeutic Effects Between 
The Two Groups (Table 1).
Table 1. Comparison of total therapeutic effects between the two group 
Group n Cured Relieved Improved Failed Total Effective Rate
Treatment 32 11 (34.4) 14 (43.8) 3 (9.4) 4 (12.5)  28 (87.5%)Ʒ
Control 30 6 (20.0) 4 (13.3) 13 (43.3) 7 (23.3) 23 (76.7%)
Notes: ƷP<0.01, compared with control group (CMH Ȥ2=6.62, P=0.01), indicating the total effective rate in the 
treatment group was obviously better than that in the control group. 
Changes in Symptoms of Headache (Table 2) 
As shown in Table 2, compared with the data 
obtained before treatment, all the indices were 
significantly improved (P<0.01), indicating good 
effects were achieved in both groups concerning the 
frequency of the attacks and alleviation of pain. The 
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differences were significant, compared between the 
two groups (P<0.05), indicating the superiority of 
acupuncture plus Chinese herbal decoction to 
Chinese herbal decoction alone in reducing the 
severity of headache. 
Table 2. Scores for evaluating the symptoms of headache ( x fs, scores)
Group Time Number of times Number of days Duration Severity 
Before treat. 3.75f1.14 4.16f0.88 3.81f0.93 4.19f0.78 
After treat.  1.72f1.25*  2.34f1.66*  2.00f1.52*  1.59f1.43*
Treatment  
Difference 2.03f1.64 1.81f1.73 1.81f1.40  2.59f1.64Ʒ
Before treat. 3.73f1.08 4.07f0.91 3.93f0.83 4.03f0.81 
After treat.   2.60f1.38*  2.97f1.50*  2.67f1.45* 2.57f1.36 
Control 
Difference 1.13f2.08 1.10f1.45 1.27f1.31 1.47f1.33 
Notes: *P<0.01, compared before and after treatment; ƷP=0.045, compared with the control group 
(t=3.893) with significant difference between the two groups (P<0.05). 
Follow-up 
During a follow-up of half a year, 3 cases in the 
treatment group had a relapse, including 2 relieved 
cases and 1 improved case, amounting to 9.4%, and 5
cases in the control group had a recurrence, including 
1 cured case, 1 relieved case and 3 improved cases, 
amounting to 16.7%. 
DISCUSSION 
According to TCM, angioneurotic headache pertains 
to head-wind, brain-wind and hemi-head-wind. As 
stated in the treatise on headache in Medical 
Regulations (एᵫ㓇๼g༈⮯), the symptom of 
head-wind is not different to that of headache, but it 
can be differentiated based on its features of attack. 
Recent acute attack is called headache, and it is easy 
to expel, while chronic prolonged and repetitive 
attack is called head-wind, and it is easy to relapse. 
Being the confluent location of all the yang meridians 
and the lucid yang palace, when the brain is invaded 
by exogenous wind, or injured by seven emotions, 
improper diet and over fatigue, lucid yang can be 
obstructed, meridians and collaterals blocked to cause 
unsmooth qi and blood flow and obstructed cerebral 
vessels, leading to headache. As said in the treatise 
on headache in Classified Treatment˄㉏䆕⊏㺕g༈
⮯ ,˅ the head is the confluent location of all the yang
meridians. When it is invaded by six exogenous 
pathogenic factors, the essence is obstructed and 
stagnated to cause failure of transportation of lucid 
yang, resulting in headache. In an overall viewpoint, 
headache is often an excess syndrome caused either 
by wind that attacks the Liver Meridian, making liver 
yang upward disturbing the head or due to blood 
stasis or phlegm. The authors applied acupuncture 
combined with oral administration of Chinese herbal 
decoction to treat the disease by way of both 
acupuncture for suppressing the hyperactive liver and 
subsiding yang to eliminate wind, and unblocking 
meridians and activating collaterals to relieve pain, 
and Chinese herbs for moving qi and activating blood, 
dispelling wind, resolving stasis and pacifying the 
liver.  
The present study showed that the total effective rate 
of acupuncture plus Chinese herbs was 87.5%, which 
was significantly better than total effective rate of 
76.7% in Chinese herbal decoction given alone 
(P<0.05). Statistically, both the therapies could 
achieve obvious therapeutic effects on reducing 
attack frequency (P<0.01), number of days with 
attack (P<0.01), duration of attack (P<0.01) and 
alleviating its intensity (P<0.01). No significant 
differences in reducing all the above-mentioned 
indices were found between the two groups (P>0.05) 
except the index of the attack intensity, in which the 
combined therapy was better than the simple one 
(P<0.05). During a follow-up of half a year, 3 cases 
in the treatment group, amounting to 9.4%, and 5 
cases in the control group, amounting to 16.7% had a 
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relapse respectively. It suggested that acupuncture 
combined with oral administration of Chinese herbal 
decoction achieved remarkable therapeutic effects in 
treating vascular headache, for which it is worth 
popularizing.  
Moreover, it is suggested from the present study that 
there may be synergistic relations between 
acupuncture and medication, i.e., the effect of the 
combination may be better than any of the single one. 
Its mechanisms remain to be investigated further both 
basically and theoretically by elucidating regulative 
effects of acupuncture and pharmacological 
mechanisms of related Chinese herbs, so as to 
provide theoretical bases of the combined therapy for 
treating vascular headache to elevate its clinical 
therapeutic effects further.  
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